Zealand Pharma schedules Extraordinary General Meeting for May 26, 2026, to discuss key company matters.

Zealand Pharma, a biotech firm specializing in metabolic health, has announced an Extraordinary General Meeting (EGM) set for May 26, 2026, in Copenhagen. The meeting will be held physically without a live webcast or recording, focusing on important company decisions including board elections. This event is significant as it may influence the company's strategic direction and governance. Investors and stakeholders are advised to review the accompanying materials for agenda details and participation instructions.